KPV 30mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of KPV supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-KPV30-B241

Key analytical results include:

• Assay Content: 31.1 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 997
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

KPV is a short synthetic peptide frequently studied in controlled laboratory environments investigating peptide-mediated signalling pathways and cellular regulatory mechanisms.

The compound belongs to a class of tripeptides derived from naturally occurring peptide sequences involved in biochemical signalling processes.

This preparation contains 30 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, KPV has become a widely referenced molecule in experimental models studying peptide signalling and cellular regulatory pathways.

Compound Overview

KPV is a synthetic tripeptide composed of the amino acid sequence Lysine–Proline–Valine.

The peptide is derived from a fragment of alpha-melanocyte stimulating hormone (α-MSH), a naturally occurring signalling peptide involved in several biochemical regulatory systems.

Within biochemical research environments, KPV is frequently examined in experimental models investigating peptide-mediated signalling pathways and intracellular regulatory mechanisms.

These research models allow scientists to explore molecular signalling processes associated with peptide fragments and cellular communication systems.

Historical Background and Scientific Context

Interest in peptide fragments derived from endogenous signalling molecules expanded significantly during the late twentieth century as molecular biology techniques improved.

Researchers studying melanocortin signalling pathways identified several short peptide fragments capable of interacting with biochemical regulatory systems.

Among these fragments, the KPV tripeptide became a molecule of interest in experimental models investigating peptide signalling and cellular regulatory processes.

Since that time, KPV has remained a commonly referenced compound in laboratory research exploring peptide fragment signalling systems.

Mechanistic Focus in Research

Within experimental laboratory environments, KPV is often studied in relation to peptide-mediated signalling pathways and cellular regulatory networks.

Research investigations commonly explore the compound in experimental models examining:

• Peptide fragment signalling pathways
• Melanocortin-related biochemical signalling systems
• Intracellular regulatory signalling networks
• Comparative peptide fragment interaction research
• Cellular communication pathway modelling
• Peptide-mediated biochemical regulation
• Experimental peptide signalling dynamics

These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated cellular communication.

Research Applications

In controlled research environments, KPV may be utilised in experimental models designed to explore peptide signalling systems and intracellular regulatory networks.

Examples of research applications include:

• Peptide signalling pathway investigation
• Cell signalling network analysis
• Intracellular regulatory pathway modelling
• Comparative peptide compound evaluation
• Biochemical signalling research
• Peptide fragment interaction studies
• Controlled in vitro peptide signalling experiments

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 31.1 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin detected but below 0.01 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.